BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36920864)

  • 1. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research to advance the health of people with inherited bleeding disorders with the potential to menstruate.
    Baldwin MK; Ahmadzia HK; Bartlett DL; Bensen-Kennedy D; Desai V; Haley KM; Herman-Hilker SL; Kilgore AM; Kulkarni R; Lavin M; Luckey S; Matteson KA; Paulyson-Nuñez K; Philipp CS; Ragosta S; Rosen K; Rotellini D; Weyand AC
    Expert Rev Hematol; 2023 Mar; 16(sup1):71-86. PubMed ID: 36920864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders.
    Nugent D; Acharya SS; Baumann KJ; Bedrosian C; Bialas R; Brown K; Corzo D; Haidar A; Hayward CPM; Marks P; Menegatti M; Miller ME; Nammacher K; Palla R; Peltier S; Pruthi RK; Recht M; Sørensen B; Tarantino M; Wolberg AS; Shapiro AD
    Expert Rev Hematol; 2023 Mar; 16(sup1):55-70. PubMed ID: 36920862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia.
    Tran DQ; Benson CC; Boice JA; Chitlur M; Dunn AL; Escobar MA; Gupta K; Johnsen JM; Jorgenson J; Martin SD; Martin S; Meeks SL; Narvaez AA; Quon DV; Reding MT; Reiss UM; Savage B; Schafer K; Steiner B; Thornburg C; Volland LM; von Drygalski A
    Expert Rev Hematol; 2023 Mar; 16(sup1):19-37. PubMed ID: 36920859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders.
    Sidonio RF; Bryant PC; Di Paola J; Hale S; Heiman M; Horowitz GS; Humphrey C; Jaffray J; Joyner LC; Kasthuri R; Konkle BA; Kouides PA; Montgomery R; Neeves K; Randi AM; Scappe N; Tarango C; Tickle K; Trapane P; Wang M; Waters B; Flood VH
    Expert Rev Hematol; 2023 Mar; 16(sup1):39-54. PubMed ID: 36920856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities in health services; diversity, equity, and inclusion; and implementation science.
    Byams VR; Baker JR; Bailey C; Connell NT; Creary MS; Curtis RG; Dinno A; Guelcher CJ; Kim M; Kulkarni R; Lattimore S; Norris KL; Ramirez L; Skinner MW; Symington S; Tobase P; Vázquez E; Warren BB; Wheat E; Buckner TW
    Expert Rev Hematol; 2023 Mar; 16(sup1):87-106. PubMed ID: 36920863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding.
    Ragni MV; Young G; Batsuli G; Bisson E; Carpenter SL; Croteau SE; Cuker A; Curtis RG; Denne M; Ewenstein B; Federizo A; Frick N; Funkhouser K; George LA; Hoots WK; Jobe SM; Krava E; Langmead CJ; Lewis RJ; López J; Malec L; Mann Z; Miles ME; Neely E; Neufeld EJ; Pierce GF; Pipe SW; Pitler LR; Raffini L; Schnur KM; Shavit JA
    Expert Rev Hematol; 2023 Mar; 16(sup1):107-127. PubMed ID: 36920855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Building the blueprint: Formulating a community-generated national plan for future research in inherited bleeding disorders.
    Valentino LA; Witkop ML; Santaella ME; DiMichele D; Recht M
    Haemophilia; 2022 Sep; 28(5):760-768. PubMed ID: 35700441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The National Hemophilia Foundation State of the Science Research Summit initiative: executive summary.
    Valentino LA; Witkop ML; Santaella ME; DiMichele D; Recht M
    Expert Rev Hematol; 2023 Mar; 16(sup1):129-134. PubMed ID: 36920857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menstruation: science and society.
    Critchley HOD; Babayev E; Bulun SE; Clark S; Garcia-Grau I; Gregersen PK; Kilcoyne A; Kim JJ; Lavender M; Marsh EE; Matteson KA; Maybin JA; Metz CN; Moreno I; Silk K; Sommer M; Simon C; Tariyal R; Taylor HS; Wagner GP; Griffith LG
    Am J Obstet Gynecol; 2020 Nov; 223(5):624-664. PubMed ID: 32707266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Big picture initiatives in bleeding disorders.
    Rauch A; Valentino LA; Mills K; Witkop ML; Santaella ME; DiMichele D; Recht M; Susen S
    Haemophilia; 2022 May; 28 Suppl 4():53-60. PubMed ID: 35521733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lived experience experts: a name created by us for us.
    Vázquez E; Kim M; Santaella ME
    Expert Rev Hematol; 2023 Mar; 16(sup1):7-11. PubMed ID: 36920861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of medical or surgical treatment for women with heavy menstrual bleeding: the ECLIPSE trial 10-year observational follow-up study.
    Kai J; Dutton B; Vinogradova Y; Hilken N; Gupta J; Daniels J
    Health Technol Assess; 2023 Oct; 27(17):1-50. PubMed ID: 37924269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women and inherited bleeding disorders - A review with a focus on key challenges for 2019.
    Winikoff R; Scully MF; Robinson KS
    Transfus Apher Sci; 2019 Oct; 58(5):613-622. PubMed ID: 31582329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community.
    Robinson F; Wilkes S; Schaefer N; Goldstein M; Rice M; Gray J; Meyers S; Valentino LA
    Ther Adv Drug Saf; 2023; 14():20420986221146418. PubMed ID: 36861041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges of diagnosing and managing the adolescent with heavy menstrual bleeding.
    Zia A; Rajpurkar M
    Thromb Res; 2016 Jul; 143():91-100. PubMed ID: 27208978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using human-centered design to co-design dedicated menstrual health spaces with people who menstruate in Bidi Bidi refugee settlement, Uganda: Learnings for further adaptation and scale in humanitarian settings.
    Beeman A; Kwesiga J; Ippoliti N; Bhandari T; Pandya G; Acam FA; Lee S; Hope R; Gibbs T; Levine J
    BMC Womens Health; 2023 Jun; 23(1):319. PubMed ID: 37340385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "If I wasn't a girl": Experiences of adolescent girls with heavy menstrual bleeding and inherited bleeding disorders.
    Parker M; Hannah M; Zia A
    Res Pract Thromb Haemost; 2022 May; 6(4):e12727. PubMed ID: 35664533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.